Citius Pharmaceuticals, Inc.CTXRNASDAQ
Loading
Cost of Revenue Over TimeExpanding
Percentile Rank100
3Y CAGR+98.6%
5Y CAGR+56.0%
Year-over-Year Change
Direct costs attributable to producing goods sold
3Y CAGR
+98.6%/yr
vs +284.1%/yr prior
5Y CAGR
+56.0%/yr
Recent acceleration
Acceleration
-185.5pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
9.2x
Strong expansion
Streak
7 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $1.52M | +610.4% |
| 2025 | $214250.00 | +2.2% |
| 2024 | $209611.00 | +7.9% |
| 2023 | $194316.00 | +8.1% |
| 2022 | $179677.00 | +9.0% |
| 2021 | $164868.00 | +8.2% |
| 2020 | $152364.00 | +16962.0% |
| 2019 | $893.00 | -49.1% |
| 2018 | $1753.00 | -33.4% |
| 2017 | $2632.00 | - |